Transcription activator-like effector base editing delivered by a targeted lipid nanoparticle for therapy of lung cancer.
A transcription activator-like effector (TALE) base editor that can accurately identify KRAS gene under the guide of TALE and sgRNA, convert C base to T base and generate a stop codon and blocking the expression of KRAS is reported.